{
  "$schema": "folio-library-document/v1",
  "id": "10665-67518",
  "title": "Caracteristiques d' activité et de stabilité des vaccines antivarioliques utilisés dans les programmes d' éradication de la variole en Afrique de l' ouest et du centre-ouest / par A. Bernstein et M.Z. Bierly",
  "variant": "pdf",
  "pages": 17,
  "tocSource": "none",
  "tocMethod": null,
  "toc": [],
  "sections": [
    {
      "id": "page-001",
      "number": null,
      "title": "Page 1",
      "level": 1,
      "pageStart": 1,
      "pageEnd": 1,
      "labelStart": null,
      "labelEnd": null,
      "words": 534,
      "summary": {
        "text": "The first page of a 1972 WHO report in French on the potency and stability of smallpox vaccines used in the eradication programme in West and Central-West Africa, with a partly garbled OCR title. It credits the near-eradication of smallpox in the region to careful surveillance, effective vaccination and a heat-stable vaccine. It introduces the laboratory titrations and field tests reported, along with standard WHO distribution notices.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "par wyeth",
          "heading": false
        },
        {
          "term": "vaccin antivariolique",
          "heading": false
        },
        {
          "term": "titrage mca",
          "heading": false
        },
        {
          "term": "sur les",
          "heading": false
        },
        {
          "term": "dans les",
          "heading": false
        },
        {
          "term": "l'united states",
          "heading": false
        },
        {
          "term": "lymphe",
          "heading": false
        },
        {
          "term": "produit",
          "heading": false
        }
      ],
      "extract": "WORLD HEALTH ORGANIZATION WHo/SE/72.49 ! ORGANISATION MONDIALE DE LA SANTÉ ORIGINAL : ANGLAIS ERISTIQUES D'ACTIVITE ET DE STABILITE DES VACCINS ANTIVARIOLIQUES UTILISES DANS LES PROGRAMMES D'ERADICATION DE LA VARIOLE EN AFRIQUE DE L'OUEST ET DU CENTRE-OUEST par 1 1 le Dr A. Bernstein et le Dr M. Z,. Bieriy, jr L'éradication virtuelle de la variole dans l'ouest et le centre-ouest de l'Afrique prouve que l'objectif",
      "extractCut": true,
      "blocks": [
        "library/10665-67518/blocks/prose-page-001"
      ]
    },
    {
      "id": "page-002",
      "number": null,
      "title": "Page 2",
      "level": 1,
      "pageStart": 2,
      "pageEnd": 2,
      "labelStart": null,
      "labelEnd": null,
      "words": 737,
      "summary": {
        "text": "Reports titration results for the reference vaccine and production lots for jet injector and bifurcated needle use, showing most lots met potency standards. It begins describing how the source of embryonated eggs, embryo age and inoculum volume affect titration on the chorioallantoic membrane. The OCR text contains garbled units and symbols.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "des oeufs",
          "heading": false
        },
        {
          "term": "des embryons",
          "heading": false
        },
        {
          "term": "les oeufs",
          "heading": false
        },
        {
          "term": "oeufs embryonnés",
          "heading": false
        },
        {
          "term": "sur embryons",
          "heading": false
        },
        {
          "term": "des inoculums",
          "heading": false
        },
        {
          "term": "les titres",
          "heading": false
        },
        {
          "term": "vaccin inoculer",
          "heading": false
        }
      ],
      "extract": "WHO/SE/72 .49 Page 2 Le titre moyen du vaccin de référence, calculé d'a près 399 titrages MCA effectués en cinq ans et demi, était de 8,3 logo U.inf./m1, avec un écart type de 0,13. Un titrage était considéré comme valable si le titre du vaccin de référence n'était pas inférieur à 8,0 ni supérieur à 8,6 lo U.inf./ml. Les lots de vaccin produit étaient considérés comme équivalents au vaccin de référence si leur titre",
      "extractCut": true,
      "blocks": [
        "library/10665-67518/blocks/prose-page-002"
      ]
    },
    {
      "id": "page-003",
      "number": null,
      "title": "Page 3",
      "level": 1,
      "pageStart": 3,
      "pageEnd": 3,
      "labelStart": null,
      "labelEnd": null,
      "words": 700,
      "summary": {
        "text": "Explains that smaller inoculum volumes and older embryos gave higher titres and lower variability, recommending standardised conditions for titration. It begins describing field trials in revaccinated young adults to relate titre to the rate of major skin reactions.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "des embryons",
          "heading": false
        },
        {
          "term": "vaccin antivariolique",
          "heading": false
        },
        {
          "term": "d'un vaccin",
          "heading": false
        },
        {
          "term": "référence non",
          "heading": false
        },
        {
          "term": "des oeufs",
          "heading": false
        },
        {
          "term": "les inoculums",
          "heading": false
        },
        {
          "term": "chez les",
          "heading": false
        },
        {
          "term": "nous avons",
          "heading": false
        }
      ],
      "extract": "wHo/sE/72.49 Page 3 les inoculums de O,1 ml ou 0,2 ml. On voit sur la figure 1 que la pente des courbes est la même pour tous les inoculums. Le titrage d'un vaccin lyophilisé stocké à 35 C pendant 30 jours a donné lieu aux mêmes observations. : Le tableau 4 met en évidence l'effet combiné du volume de l'inoculum et de l'âge des oeufs embryonnés sur le titre MCA du vaccin de référence, Le titre moyen a été le plus",
      "extractCut": true,
      "blocks": [
        "library/10665-67518/blocks/prose-page-003"
      ]
    },
    {
      "id": "page-004",
      "number": null,
      "title": "Page 4",
      "level": 1,
      "pageStart": 4,
      "pageEnd": 4,
      "labelStart": null,
      "labelEnd": null,
      "words": 741,
      "summary": {
        "text": "Reports that major reaction rates were similar across 18 vaccinated groups and changed little with dilution except at 1:100, suggesting current potency standards exceed what is needed. It compares titrations on embryonated eggs and cell culture and notes the virus strains behind different reference vaccines.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "référence dilué",
          "heading": false
        },
        {
          "term": "vaccin témoin",
          "heading": false
        },
        {
          "term": "préparation témoin",
          "heading": false
        },
        {
          "term": "non dilué",
          "heading": false
        },
        {
          "term": "réaction majeure",
          "heading": false
        },
        {
          "term": "les réactions",
          "heading": false
        },
        {
          "term": "deux bras",
          "heading": false
        },
        {
          "term": "vaccin expertiser",
          "heading": false
        }
      ],
      "extract": "WHO/SE/72.49 Page 4 résultats sont également présentés sous forme de rapport entre le pourcentage d'individus ayant présenté une réaction majeure sur le bras ayant reçu le vaccin à expertiser (vaccin de référence dilué ou non dilué) et le pourcentage d'individus ayant eu une réaction majeure sur le bras inoculé avec le témoin (vaccin de référence non dilué), La sensibilité des 18 groupes vaccinés sur une période de",
      "extractCut": true,
      "blocks": [
        "library/10665-67518/blocks/prose-page-004"
      ]
    },
    {
      "id": "page-005",
      "number": null,
      "title": "Page 5",
      "level": 1,
      "pageStart": 5,
      "pageEnd": 5,
      "labelStart": null,
      "labelEnd": null,
      "words": 743,
      "summary": {
        "text": "Describes stability studies of freeze-dried Dryvax vaccine stored at various temperatures, showing only modest titre loss after months at 25°C or 37°C. It reports long-term stability at 2–8°C and that reconstituted vaccine lost potency faster with a diluent containing phenol.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vaccins stockés",
          "heading": false
        },
        {
          "term": "stabilité des",
          "heading": false
        },
        {
          "term": "les vaccins",
          "heading": false
        },
        {
          "term": "vaccin réhydraté",
          "heading": false
        },
        {
          "term": "six lots",
          "heading": false
        },
        {
          "term": "pendant des",
          "heading": false
        },
        {
          "term": "des échantillons",
          "heading": false
        },
        {
          "term": "semaine pendant",
          "heading": false
        }
      ],
      "extract": "WHo/SE/72.49 Page 5 Une deuxième étude a été entreprise pour déterminer les caractéristiques de stabilité de vaccin lyophilisé de Wyeth par la méthode MCA. Les courbes de la figure 5 représentent les variations moyennes du titre pour six lots de vaccin stockés à 37°C, 25°C et 5°C, par rapport au titre du vaccin stocké à -20°C, déterminé aux mêmes intervalles, Pour le vaccin stocké à 25°C, le titre a diminué",
      "extractCut": true,
      "blocks": [
        "library/10665-67518/blocks/prose-page-005"
      ]
    },
    {
      "id": "page-006",
      "number": null,
      "title": "Page 6",
      "level": 1,
      "pageStart": 6,
      "pageEnd": 6,
      "labelStart": null,
      "labelEnd": null,
      "words": 286,
      "summary": {
        "text": "Summarises that titration conditions should be standardised and that WHO and US standards set potency higher than needed, since reaction rates did not differ between titres. It ends with references and acknowledgements, and the OCR has jumbled some lines.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "inoculum",
          "heading": false
        },
        {
          "term": "titrage",
          "heading": false
        },
        {
          "term": "des",
          "heading": false
        },
        {
          "term": "inf",
          "heading": false
        },
        {
          "term": "vaccin",
          "heading": false
        },
        {
          "term": "activité",
          "heading": false
        },
        {
          "term": "microbiol",
          "heading": false
        },
        {
          "term": "titre",
          "heading": false
        }
      ],
      "extract": "WHO/SE/72.49 Page 6 Remarques et résumé Nous avons montré que le titrage de 1' méthode MCA pouvait donner des valeurs plus faib l'âge des embryons et le volume de l'inoculum. U à savoir utilisation d'embryons âgés de 12 à 13 simultané d'un vaccin de référence afin d'évalue activité des vaccins antivarioliques par la les suivant l'origine des oeufs embryonnés, ne normalisation est donc souhaitable, jours, inoculum de",
      "extractCut": true,
      "blocks": [
        "library/10665-67518/blocks/prose-page-006"
      ]
    },
    {
      "id": "page-007",
      "number": null,
      "title": "Page 7",
      "level": 1,
      "pageStart": 7,
      "pageEnd": 7,
      "labelStart": null,
      "labelEnd": null,
      "words": 203,
      "summary": {
        "text": "Tables 1 and 2 give titration results for the US reference smallpox vaccine using eggs from different flocks and embryos of different ages, with OCR errors in the table layout.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "oeufs embryonnes",
          "heading": false
        },
        {
          "term": "oeufs embryonnés",
          "heading": false
        },
        {
          "term": "des oeufs",
          "heading": false
        },
        {
          "term": "jours",
          "heading": false
        },
        {
          "term": "titrage",
          "heading": false
        },
        {
          "term": "l'embryon",
          "heading": false
        }
      ],
      "extract": "TABLEAU 1. WHo/SE/72.49 Page 7 RESULTATS DES TITRAGES MCA DU U.S. REFERENCE SMALLPOX VACCINE LOT 2 (VACCIN DE REFERENCE) SUR OEUFS EMBRYONNES PROVENANT DE DIFFERENTS GROUPES DE POULETS Origine des oeufs Nombre de titrages Titre moyen log, U.inf./n1 Fournisseur A Groupe We Groupe Br Groupe Wa Fournisseur B Élevage de Wyeth exempt de FIR oo TABLEAU 2, INFLUENCE DE L'AGE DES OEUFS EMBRYONNES SUR LES TITRES MCA DU",
      "extractCut": true,
      "blocks": [
        "library/10665-67518/blocks/prose-page-007"
      ]
    },
    {
      "id": "page-008",
      "number": null,
      "title": "Page 8",
      "level": 1,
      "pageStart": 8,
      "pageEnd": 8,
      "labelStart": null,
      "labelEnd": null,
      "words": 162,
      "summary": {
        "text": "Tables 3 and 4 show how inoculum volume, alone and combined with embryo age, affected titration results for the reference vaccine, with OCR errors in numbers and labels.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "titrage mca",
          "heading": false
        },
        {
          "term": "ecart type",
          "heading": false
        },
        {
          "term": "l'inoculum",
          "heading": false
        },
        {
          "term": "des oeufs",
          "heading": false
        }
      ],
      "extract": "WHO/SE/72.49 Page 8 TABLEAU 3. INFLUENCE DU VOLUME DE L'INOCULUM SUR LES RESULTATS DU TITRAGE MCA DU VACCIN DE REFERENCE* Dilution du Volume de l'inoculum (ml) vaccin inoculée 0,2 0,1 0,05 0,025 -5,8 ** a 10 7,9 (26) 8,1 (20) 8,2 (13) 8,3 (8) io”$0 7,9 GT) 8,2 (16) 8,3 (11) 8,5 (9) 10762 8,1 (5) 8,2 (11) 8,4 (7) 8,8 (10) Résultats combinés de 4 titrages. ** Titre infectant en log, QU.inf./m. a — Nombre moyen de",
      "extractCut": true,
      "blocks": [
        "library/10665-67518/blocks/prose-page-008"
      ]
    },
    {
      "id": "page-009",
      "number": null,
      "title": "Page 9",
      "level": 1,
      "pageStart": 9,
      "pageEnd": 9,
      "labelStart": null,
      "labelEnd": null,
      "words": 298,
      "summary": {
        "text": "Tables 5 and 6 report major reaction rates in revaccinated young adults given diluted and undiluted reference vaccine by bifurcated needle and relate these to titration results, with some garbled OCR.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vaccin témoin",
          "heading": false
        },
        {
          "term": "non dilué",
          "heading": false
        },
        {
          "term": "rapport vaccin",
          "heading": false
        },
        {
          "term": "réactions majeures",
          "heading": false
        },
        {
          "term": "moyenne intervalle",
          "heading": false
        },
        {
          "term": "adultes revaccines",
          "heading": false
        },
        {
          "term": "jeunes adultes",
          "heading": false
        }
      ],
      "extract": "wxo/SE/12.49 Page 9 TABLEAU 5, REACTIONS A LA VACCINATION AVEC DES PREPARATIONS NON DILUBES ET DILUEES DU VACCIN DE REFERENCE ADMINISTREES PAR AIGUILLE BIFIDE DE WYETH, CHEZ DE JEUNES ADULTES REVACCINES i i Nombre de réactions majeures Dilution du Nombre j Rapport B/A vaccin de : de sur les bras ayant reçu : référence Nombre sujets Vaccin Vaccin à d'essais Je témoin** expertiser Vaccin à vaccinés Moyenne Intervalle",
      "extractCut": true,
      "blocks": [
        "library/10665-67518/blocks/prose-page-009"
      ]
    },
    {
      "id": "page-010",
      "number": null,
      "title": "Page 10",
      "level": 1,
      "pageStart": 10,
      "pageEnd": 10,
      "labelStart": null,
      "labelEnd": null,
      "words": 166,
      "summary": {
        "text": "Tables 7 and 8 compare reference vaccine titres on egg membranes and cell culture and show the stability of reconstituted Dryvax under different storage conditions.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "par semaine",
          "heading": false
        },
        {
          "term": "référence",
          "heading": false
        },
        {
          "term": "vaccin",
          "heading": false
        },
        {
          "term": "mca",
          "heading": false
        }
      ],
      "extract": "wHo/SE/72.49 Page 10 TABLEAU 7, TITRAGE DU VACCIN DE REFERENCE ET DE LA PREPARATION INTERNATIONALE DE REFERENCE SUR MCA ET SUR CULTURE CELLULAIRE RSC Vaccin de référence Titre MCA Titre CMK Rapport des titres l U.i 8,0 V-inf./m1 log 10 10Ts 0/1 RSC/MCA Préparation interna- tionale de référence 8,3 7,4 -0,9 Vaccin de référence 8,4 8,8 +0,4 Vaccin de référence de Wyeth 7,9 8,2 +0,3 TABLEAU 8. ETUDE DE LA STABILITE DU",
      "extractCut": true,
      "blocks": [
        "library/10665-67518/blocks/prose-page-010"
      ]
    },
    {
      "id": "page-011",
      "number": null,
      "title": "Page 11",
      "level": 1,
      "pageStart": 11,
      "pageEnd": 11,
      "labelStart": null,
      "labelEnd": null,
      "words": 155,
      "summary": {
        "text": "Table 9 gives skin reaction rates in revaccinated young adults given reconstituted Dryvax stored at 2–8°C for up to 17 weeks.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "dryvax",
          "heading": false
        },
        {
          "term": "vaccin",
          "heading": false
        },
        {
          "term": "inf",
          "heading": false
        }
      ],
      "extract": "TABLEAU 9, wHo/SE/72.49 Page 11 REACTIONS CUTANEES CHEZ DE JEUNES AQULTES REVACCINES AU MOYEN % DE L'AIGUILLE BIFIDE DE WYETH AVEC DU VACCIN DRYVAX RECONSTITUE, STOCKE A 2-8°C i i Pourcentage de réactions majeures Durée du Titre MCA Nombre de Vaccin de réfé- Vaccin à Rapport stockage Joe sujets rence A** expertiser B B/A (semaines) |U.inf./m1 vaccinés Nombre 2 Nombre % o 8,4 86 62 (72) 59 (69) 0,96 4 8,1 60 37 (62)",
      "extractCut": true,
      "blocks": [
        "library/10665-67518/blocks/prose-page-011"
      ]
    },
    {
      "id": "page-012",
      "number": null,
      "title": "Page 12",
      "level": 1,
      "pageStart": 12,
      "pageEnd": 12,
      "labelStart": null,
      "labelEnd": null,
      "words": 114,
      "summary": {
        "text": "Table 10 shows titre changes in reconstituted jet-injector smallpox vaccine stored at 5°C, 25°C and 37°C with and without phenol in the diluent.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "heures",
          "heading": false
        },
        {
          "term": "temps diluant",
          "heading": false
        },
        {
          "term": "phénol",
          "heading": false
        }
      ],
      "extract": "wxo/sE/72.49 Page 12 TABLEAU 10. CARACTERISTIQUES DE STABILITE DU VACCIN ANTIVARIOLIQUE RECONSTITUE, DESTINE À ETRE ADMINISTRE PAR INJECTEUR SANS AIGUILLE Los 4 * Stockage Variations du titre Gog10oDICT50/m1) à partir du temps O ° Diluant avec 0,25 % Tempé : 2 , empérature Temps Diluant sans phénol de phénol 5°c 8 heures 0,0 -0,1 24 heures 0,1 0,1 32 heures 0,0 -0,1 25°C 8 heures 0,0 -0,1 24 heures 0,0 -0,2 32",
      "extractCut": true,
      "blocks": [
        "library/10665-67518/blocks/prose-page-012"
      ]
    },
    {
      "id": "page-013",
      "number": null,
      "title": "Page 13",
      "level": 1,
      "pageStart": 13,
      "pageEnd": 13,
      "labelStart": null,
      "labelEnd": null,
      "words": 173,
      "summary": {
        "text": "Figures 1 and 2, rendered as largely garbled OCR, show titration results with different inoculum volumes and the stability of freeze-dried Dryvax at high temperatures.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "titrage",
          "heading": false
        },
        {
          "term": "boss",
          "heading": false
        },
        {
          "term": "mamans",
          "heading": false
        }
      ],
      "extract": "wxo/SE/72.49 Page 13 FIGURE 1, RESULTATS DU TITRAGE MCA AVEC t DES INOCULUMS DE 0,2, O,1 ET 0,0025 ml boss DS INOCULUM el ANS i >. © 0025 FRE KR O0! Î|m £ 78 a O2 D o 74 8 70 z 66 ou [al Le} g 52 ST ; 58 NS Es 54 1 1 L n L L NS 00 05 LO 1.5 20 25 30 DILUTION DE LA SUSPENSION VIRALE G/108,.) FIGURE 2. ETUDES DE LA STABILITE DU pryvax® — VACCIN LYOPHILISE STOCKE A 37°, 50°, 70° ET 100°C - TITRAGE SUR CULTURES DE",
      "extractCut": true,
      "blocks": [
        "library/10665-67518/blocks/prose-page-013"
      ]
    },
    {
      "id": "page-014",
      "number": null,
      "title": "Page 14",
      "level": 1,
      "pageStart": 14,
      "pageEnd": 14,
      "labelStart": null,
      "labelEnd": null,
      "words": 157,
      "summary": {
        "text": "Figures 3 and 4, rendered as largely garbled OCR, show Dryvax stability over two years at several temperatures and compare titres from cell culture and egg membrane methods.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vaccin antivariolique",
          "heading": false
        },
        {
          "term": "rsc",
          "heading": false
        },
        {
          "term": "mca",
          "heading": false
        }
      ],
      "extract": "wHo/sE/72.49 Page 14 VARIATION DU TITRE FIGURE 3. ETUDES DE IA STABILITE DU pryva © — VACCIN LYOPHILISE STOCKE À 5°, 25°, 37°, 50°, et 70°C = TITRAGE SUR CULTURES DE CELLULES RSC al <, Le] 5 EN 30 à CA = A 4 40 FT 50°C SO dt nn 6 nn np pt à à pp y à 1 ‘ 3 6 9 12 15 18 el 24 DUREE DU STOCKAGE (EN MOIS) DRYVA - Vaccin antivariolique lyophilisé FIGURE 4, COMPARAISON DES TITRES OBTENUS SUR CULTURE CELLULAIRE RSC ET SUR",
      "extractCut": true,
      "blocks": [
        "library/10665-67518/blocks/prose-page-014"
      ]
    },
    {
      "id": "page-015",
      "number": null,
      "title": "Page 15",
      "level": 1,
      "pageStart": 15,
      "pageEnd": 15,
      "labelStart": null,
      "labelEnd": null,
      "words": 172,
      "summary": {
        "text": "A duplicate scan of Figures 1 and 2 on titration results and Dryvax heat stability; the extracted text is largely garbled OCR.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "titrage",
          "heading": false
        },
        {
          "term": "pryvax",
          "heading": false
        },
        {
          "term": "inoculums",
          "heading": false
        }
      ],
      "extract": "wxo/sE/72.49 Page 13 FIGURE 1. RESULTATS DU TITRAGE MCA AVEC : DES INOCULUMS DE 0,2, O,1 ET O,0025 ml 807. 86fe INOCULUM ei A j ° € 82 0025 °0/ ml Ë 78 a 02 [=] o 74 g 70 re] z 66 su & 62 . E : 58 NS o Ë 54 L L 1 A LL H 00 05 he) 1.5 20 25 30 DILUTION DE LA SUSPENSION VIRALE G/108,.) FIGURE 2. ETUDES DE LA STABILITE DU pyvax® - VACCIN LYOPHILISE STOCKE A 37°, 50°, 70° ET 100°C - TITRAGE SUR CULTURES DE CELLULES RSC",
      "extractCut": true,
      "blocks": [
        "library/10665-67518/blocks/prose-page-015"
      ]
    },
    {
      "id": "page-016",
      "number": null,
      "title": "Page 16",
      "level": 1,
      "pageStart": 16,
      "pageEnd": 16,
      "labelStart": null,
      "labelEnd": null,
      "words": 164,
      "summary": {
        "text": "A duplicate scan of Figures 3 and 4 on Dryvax stability and comparison of titration methods; the extracted text is largely garbled OCR.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vaccin antivariolique",
          "heading": false
        },
        {
          "term": "rsc",
          "heading": false
        },
        {
          "term": "mca",
          "heading": false
        }
      ],
      "extract": "wHo/se/72.49 Page 14 FIGURE 3, ETUDES DE LA STABILITE DU prwva - VACCIN LYOPHILISE STOCKE À 5°, 25°, 37°, 50°, et 70°C - TITRAGE SUR CULTURES DE CELLULES RSC [1 E 4 EE ES: 8 &° z 5 © 30F è & A & à £ 40 F 50°C COLE SES US ESS QUE RUE ON AE DT ONE OT EDS DR ONE SUN GRR GENS BE MEET ‘ 3 6 9 12 15 18 2l 24 DUREE DU STOCKAGE (EN MOIS) DRYVAX - Vaccin antivariolique lyophilisé FIGURE 4. COMPARAISON DES TITRES OBTENUS SUR",
      "extractCut": true,
      "blocks": [
        "library/10665-67518/blocks/prose-page-016"
      ]
    },
    {
      "id": "page-017",
      "number": null,
      "title": "Page 17",
      "level": 1,
      "pageStart": 17,
      "pageEnd": 17,
      "labelStart": null,
      "labelEnd": null,
      "words": 147,
      "summary": {
        "text": "Figures 5 and 6, rendered as largely garbled OCR, show Dryvax stability at 5°C, 25°C and 37°C and long-term storage at 2–8°C.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "WHo/SE/72 .49 : Page 15 * FIGURE 5. ETUDE DE IA STABILITE DU pryva® 7 VACCIN LYOPHILISE STOCKE À 5°, 25°, et 37°C en , MITRAGE MOA | & (e) I ——, SC CPR D\" ES Ro, 250 25 -05F x 25 . ES X 37°C < ä -|0 1 1 1 1 1 1 L F] S 3 6 9 12 15 18 21 24 DUREE DU STOCKAGE (EN MOIS) * Variation moyenne du titre de 6 lots de vaccin pour administration par injecteur sans aiguille DRYVA. - Vaccin antivariolique lyophilisé FIGURE 6.",
      "extractCut": true,
      "blocks": [
        "library/10665-67518/blocks/prose-page-017"
      ]
    }
  ],
  "checks": {},
  "withheld": false,
  "keywords": [
    {
      "term": "vaccin antivariolique",
      "heading": false
    },
    {
      "term": "titrage mca",
      "heading": false
    },
    {
      "term": "vaccin témoin",
      "heading": false
    },
    {
      "term": "vaccin expertiser",
      "heading": false
    },
    {
      "term": "rapport vaccin",
      "heading": false
    },
    {
      "term": "vaccin lyophilisé",
      "heading": false
    },
    {
      "term": "titre mca",
      "heading": false
    },
    {
      "term": "d'un vaccin",
      "heading": false
    },
    {
      "term": "vaccin stockés",
      "heading": false
    },
    {
      "term": "vaccin réhydraté",
      "heading": false
    },
    {
      "term": "sur mca",
      "heading": false
    },
    {
      "term": "vaccin lyophilise",
      "heading": false
    }
  ],
  "coverage": [
    {
      "kind": "contents",
      "state": "not-extracted",
      "note": "split one section per page; no contents was trusted"
    },
    {
      "kind": "sections",
      "state": "partial",
      "count": 17,
      "note": "one per page, not by heading"
    },
    {
      "kind": "figures",
      "state": "none"
    },
    {
      "kind": "tables",
      "state": "not-extracted"
    },
    {
      "kind": "references",
      "state": "none",
      "note": "no such heading in the text"
    },
    {
      "kind": "glossary",
      "state": "none",
      "note": "no such heading in the text"
    },
    {
      "kind": "footnotes",
      "state": "not-extracted"
    },
    {
      "kind": "summaries",
      "state": "found",
      "count": 17,
      "note": "17 of 17 sections"
    }
  ],
  "links": {
    "repo": "litlfred/who-iris",
    "branch": "main",
    "dir": "library/10665-67518"
  }
}
